Pharvaris (PHVS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Pharvaris (PHVS) is Neutral.

The composite score behind that read is -0.01, weighing +0.18 of bullish evidence against -0.28 bearish.

Pharvaris last closed at $31.10, -0.06% on the session.

Against the IVW growth benchmark the position is -0.86% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

Pharvaris has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Pharvaris in the 16th percentile on return on equity, where 100 is best.

Pharvaris is classified under Health Care / Pharmaceuticals, with a market capitalisation of $2.18B.

StockMap tracks Pharvaris as the 40th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Pharvaris ranks 61st of 151 in the group, against a group median of -0.08.